Learn / RGEN
NASDAQ: RGEN
Repligen (RGEN) stock, explained like you're 5
Repligen trades on the Nasdaq under the ticker RGEN. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 8.5 billion dollars.
- Ticker
- RGEN
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Mid cap, about 8.5 billion dollars
Is Repligen a small, medium or large cap company?
No. Repligen is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 8.5 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Repligen makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves RGEN stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Replimune Group (REPL) Stock Looks Rich After A 141% Run (Yahoo Finance)
- Repligen (NasdaqGS:RGEN) Stock Forecast & Analyst Predictions (Simply Wall Street)
- Repligen: A Buy As Its Growth Engine Gears Up (NASDAQ:RGEN) (Seeking Alpha)
- Repligen Corp (RGEN) Stock Up 3.4% but GF Value Says Overvalued GF Score: 85/100 (GuruFocus)
- These Two Biotech Stocks Recorded Fresh Milestones Today What’s Driving Today’s Gains? (Stocktwits)
Follow RGEN in your daily brief
Each trading day at 5 PM ET we post what happened to Repligen and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow RGEN
Questions about Repligen stock
What does Repligen do?
Repligen trades on the Nasdaq under the ticker RGEN. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 8.5 billion dollars.
What is the ticker symbol for Repligen?
Repligen trades under the ticker RGEN on the Nasdaq.
What is Repligen's market cap?
Repligen is a mid cap stock with a market cap of about 8.5 billion dollars.
How does Repligen make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves RGEN stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow RGEN stock every day?
Add RGEN to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.